Previous close | 37.95 |
Open | 37.91 |
Bid | 0.00 x 800 |
Ask | 45.00 x 900 |
Day's range | 37.37 - 38.39 |
52-week range | 31.45 - 74.49 |
Volume | |
Avg. volume | 2,318,046 |
Market cap | 6.751B |
Beta (5Y monthly) | 1.27 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.29 |
Earnings date | 05 Feb 2024 - 09 Feb 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 48.57 |
The headline numbers for Catalent (CTLT) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Catalent, Inc. (NYSE:CTLT) Q1 2024 Earnings Call Transcript November 15, 2023 Catalent, Inc. beats earnings expectations. Reported EPS is $-0.1, expectations were $-0.13. Operator: Hello all, and welcome to Catalent’s First Quarter Fiscal Year 2024 Earnings Call. My name is Lydia and I’ll be your operator today. [Operator Instructions]. I’ll now hand you over to […]
Catalent (CTLT) records lower revenues in Biologics segments in its first-quarter fiscal 2024, resulting in overall soft preliminary performance.